Skip to main content

Alerts

View all our safety and medicine shortage alerts and market actions (including recalls, product alerts and product corrections).

Search

1315 result(s) found, displaying 1301 to 1315
  • Consumers are advised to be cautious with kava-containing medicines due to potential liver damage, and should seek medical advice if they experience any symptoms.
  • Health professionals are alerted to potential liver damage linked to kava-containing medicines, and are asked to review cases of unexplained hepatotoxicity.
  • This product is being recalled, due to the detection of aristolochic acids by the Therapeutic Goods Administration Laboratories. Aristolochic acids have been associated with serious adverse reactions including severe kidney damage and urinary tract cancer.
  • These products are being recalled, due to the detection of aristolochic acids by the Therapeutic Goods Administration Laboratories. Aristolochic acids have been associated with serious adverse reactions including severe kidney damage and urinary tract cancer.
  • We have been notified of spontaneous disintegration of zirconia femoral head prostheses in some batches manufactured by Saint Gobain Céramiques Avancées Desmarquest.
  • TGA has been notified of spontaneous disintegration of zirconia ceramic femoral head prostheses in some batches manufactured by Saint Gobain Ceramiques Avancees Desmarquest (France).
  • Cerivastatin has been withdrawn from sale due to severe muscle damage risks. Stop taking it immediately and consult your doctor for alternative treatments.
  • Practitioners should be aware that certain herbal products containing Aristolochia species pose serious health risks, including kidney damage and urinary tract cancer. Extreme caution is advised when using these products.
  • We are advising that there is no clinical evidence supporting the use of green-lipped mussel for cancer treatment.